Vision

A WORLD WHERE EVERY PERSON WITH DOWN SYNDROME THRIVES WITH IMPROVED HEALTH, INDEPENDENCE, AND OPPORTUNITIES TO REACH THEIR FULLEST POTENTIAL.

Mission
We accelerate research to increase availability of therapeutic, diagnostic, and medical care options and
we empower families through education, connections, and support.

Your Donation Helps

Down syndrome research offers opportunities for people of all ages with Down syndrome. Your support is essential to finding safe, effective drugs and interventions to improve health and independence. We empower families through education, connections and support. Your gift is crucial to furthering these breakthroughs.

We’ve designed a clear path to therapies

Based on recent scientific findings, our CEO, board and world renowned scientific advisors have established four priorities for funding research. We’re focused on exciting research targeting the root cause with the objective of improving health and independence for our loved ones throughout their lifetimes. Our four priorities are: preventing Alzheimer’s onset, improving cognition, developing gene therapies, and advancing understanding.

LuMind IDSC News

Q&A on COVID-19 and Down Syndrome with Dr. Nicole Baumer

Jim Hendrix, Chief Scientific Officer of LuMind IDSC Foundation and Dr. Nicole Baumer, Director of Boston Children’s Hospital Down Syndrome Program provide a brief overview of the Q&A on COVID-19 and Down syndrome that was published by a consortium of national Down syndrome organizations. Please visit our COVID-19 and Down Syndrome page for more information …

Read More

COVID-19 and Preserving Human Rights for People with Down Syndrome

As medical systems plan for a possible flood of COVID-19 patients, healthcare professionals in the United States may draft guidance to ration care in order to ensure the largest number of people will survive the pandemic. However, LuMind IDSC has read reports of at least two cases from Alabama and Washington State where the guidance …

Read More

What people are saying about us.

“I never thought I would be in a position to say, ‘We are going to take therapies forward to directly treat Down syndrome.’ Now I think that is the case. We really are in the early stages of a revolution in understanding the basis for many of the features that occur in Down syndrome.”

Dr. Roger Reeves, Johns Hopkins